Cancers of the Lymphatic System Archives - Page 2 of 5 - Together4Cancer Compass

Patients

HCPs

Home

Categories

Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This phase II, single-arm study investigated a chemotherapy-sparing frontline strategy for previously untreated mantle c...

Continue Reading

Infections after bispecific antibodies in B-cell lymphomas.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This cohort study analyzed infectious complications in 109 patients with relapsed/refractory B‑cell lymphomas treated...

Continue Reading

Implementation of CAR-T cell therapy in outpatient settings: a critical review of current literature regarding health outcomes, benefits, challenges, and future directions.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This review article examines the emerging practice of delivering CAR T‑cell therapy for hematologic malignancies in th...

Continue Reading

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This multicenter retrospective study evaluated whether rituximab maintenance after first-line bendamustine‑rituximab i...

Continue Reading

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This multicenter retrospective study assessed real-world outcomes of CD19-directed CAR T-cell therapy in 466 patients wi...

Continue Reading

Retreatment with R-CHOP-like therapy in patients with late relapse of diffuse large B-cell lymphoma.

Post category:Cancers of the Lymphatic System
Reading time:2 mins read

This retrospective BC Cancer series evaluated outcomes of re-treatment with curative‑intent R‑CHOP–like therapy in...

Continue Reading